The effects of depriving feed to facilitate transport and slaughter in sheep--a case study of cull ewes held off pasture for different periods.

AIM: To determine the ability of sheep to mobilise their body reserves after being deprived of feed prior to transport for slaughter. METHODS: A total of 240 3- and 4-year-old cull ewes were held off pasture for 0, 9, 18 or 30 hours (n=60 per group) then transported 1 hour by road, unloaded and washed, held in lairage for 3 hours then slaughtered. Blood samples were collected from a subsample of 60 unfasted ewes 1 week earlier, and from all ewes at exsanguination to determine concentrations of serum metabolites indicative of adaptation to fasting. In addition, several attributes of carcass quality were measured. RESULTS: At slaughter, increased time off pasture prior to transport resulted in no change in glucose concentrations in serum (p=0.140). There were differences (p<0.001) between the group fasted for 30 compared with 0 hours in mean concentrations of free fatty acids (0.98 (SD 0.32) vs. 0.58 (SD 0.23) mmol/L), ß-hydroxybutyrate (0.69 (SD 0.17) vs. 0.42 (SD 0.11) mmol/L), triglycerides (0.29 (min 0.13, max 0.83) vs. 0.22 (min 0.06, max 0.96) mmol/L) and urea (10.17 (SD 1.80) vs. 6.94 (SD 2.03) mmol/L). Different periods of feed deprivation had no effect (p>0.05) on carcass weights (mean 22.7, min 13.2, max 32.9 kg) or dressing out percentages (mean 40.9, min 27, max 49%). Meat ultimate pH was unaffected (p>0.05) by the period of feed deprivation but meat became darker (p<0.05) and had reduced redness (p<0.001) with increasing time off feed. CONCLUSIONS: The results suggest that sheep in variable body condition adapted to the periods of feed deprivation by mobilising their energy reserves without any evidence of metabolic depletion (e.g. depleted blood glucose or high meat pH). However, being deprived of feed they probably experience a degree of hunger.

Quantifying the effects of inactin vs Isoflurane anesthesia on gastrointestinal motility in rats using dynamic magnetic resonance imaging and spatio-temporal maps.

BACKGROUND: Anesthetics are commonly applied in animal studies of gastrointestinal (GI) function. Different anesthetics alter smooth-muscle motility in different ways. The aim of this study is to quantify and compare non-invasively with magnetic resonance imaging (MRI) the motility patterns of the rat gut when anesthetized with inactin vs isoflurane anesthetics in the fed state. METHODS: Rats were given an oral gavage of MRI contrast agent for improved visualization of the GI tract. Two-dimensional images through the jejunum of the pre- and postanesthetized rat in the fed state were acquired every 168 ms. Image registration, segmentation, and postprocessing algorithms were applied to produce spatio-temporal maps that were used to quantify peristaltic and segmental motions in the jejunum region interspersed between periods of inactivity. KEY RESULTS: There were significantly longer periods of inactivity in the rats treated with isoflurane than in those treated with inactin (179.9 ± 22.4 s vs 17.7 ± 10.3 s). The speed of propagation and wavelength of peristalsis, and the frequency and speed of pattern switching of segmental motility, were higher (p < 0.05) in rats treated with inactin. CONCLUSIONS & INFERENCES: Isoflurane and inactin anesthetics produce significantly different motility behavior with the rat's GI tract in the fed state. Isoflurane anesthetic, results in a reduced frequency of occurrence of motility periods and an overall reduced level of motility in comparison with inactin.

Improvements in high-field localized MRS of the medial temporal lobe in humans using new deformable high-dielectric materials.

The intrinsic nonuniformities in the transmit radiofrequency field from standard quadrature volume resonators at high field are particularly problematic for localized MRS in areas such as the temporal lobe, where a low signal-to-noise ratio and poor metabolite quantification result from destructive B1⁺ field interference, in addition to line broadening and signal loss from strong susceptibility gradients. MRS of the temporal lobe has been performed in a number of neurodegenerative diseases at clinical fields, but a relatively low signal-to-noise ratio has prevented the reliable quantification of, for example, glutamate and glutamine, which are thought to play a key role in disease progression. Using a recently developed high-dielectric-constant material placed around the head, localized MRS of the medial temporal lobe using the stimulated echo acquisition mode sequence was acquired at 7 T. The presence of the material increased the signal-to-noise ratio of MRS by a factor of two without significantly reducing the sensitivity in other areas of the brain, as shown by the measured B1⁺ maps. An increase in the receive sensitivity B1⁻ was also measured close to the pads. The spectral linewidth of the unsuppressed water peak within the voxel of interest was reduced slightly by the introduction of the dielectric pads (although not to a statistically significant degree), a result confirmed by using a pad composed of lipid. Using LCmodel for quantitative analysis of metabolite concentrations, the increase in signal-to-noise ratio and the slight decrease in spectral linewidth contributed to statistically significant reductions in the Cramer-Rao lower bounds (CRLBs), also allowing the levels of glutamate and glutamine to be quantified with CRLBs below 20%.

A radiofrequency coil configuration for imaging the human vertebral column at 7 T.

We describe the design and testing of a quadrature transmit, eight-channel receive array RF coil configuration for the acquisition of images of the entire human spinal column at 7 T. Imaging parameters were selected to enable data acquisition in a clinically relevant scan time. Large field-of-view (FOV) scanning enabled sagittal imaging of the spine in two or three-stations, depending upon the height of the volunteer, with a total scan time of between 10 and 15 min. A total of 10 volunteers have been scanned, with results presented for the three subjects spanning the range of heights and weights, namely one female (1.6 m, 50 kg), one average male (1.8 m, 70 kg), and one large male (1.9 m, 100 kg).

New high dielectric constant materials for tailoring the B1+ distribution at high magnetic fields.

The spatial distribution of electromagnetic fields within the human body can be tailored using external dielectric materials. Here, we introduce a new material with high dielectric constant, and also low background MRI signal. The material is based upon metal titanates, which can be made into a geometrically-formable suspension in de-ionized water. The material properties of the suspension are characterized from 100 to 400 MHz. Results obtained at 7 T show a significant increase in image intensity in areas such as the temporal lobe and base of the brain with the new material placed around the head, and improved performance compared to purely water-based gels.

Simple RF design for human functional and morphological cardiac imaging at 7tesla.

Morphological and functional cardiac MRI can potentially benefit greatly from the recent advent of commercial high-field (7tesla and above) MRI systems. However, conventional hardware configurations at lower field using a body-coil for homogeneous transmission are not available at these field strengths. Sophisticated multiple-transmit-channel systems have been shown to be able to image the human heart at 7tesla but such systems are currently not widely available. In this paper, we empirically optimize the design of a simple quadrature coil for cardiac imaging at 7tesla. The size, geometry, and position have been chosen to produce a B(1) field with no tissue-induced signal voids within the heart. Standard navigator echoes for gating were adapted for operation at the heart/lung interface, directly along the head-foot direction. Using this setup, conventional and high-resolution cine functional imaging have been successfully performed, as has morphological imaging of the right coronary artery.

Role of human CYP1A1 and NAT2 in 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-induced mutagenicity and DNA adducts.

2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) is carcinogenic in multiple organs and numerous species. Bioactivation of PhIP is initiated by PhIP N(2)-hydroxylation catalysed by cytochrome P450s. Following N-hydroxylation, O-acetylation catalysed by N-acetyltransferase 2 (NAT2) is considered a further possible activation pathway. Genetic polymorphisms in NAT2 may modify cancer risk following exposure. Nucleotide excision repair-deficient Chinese hamster ovary (CHO) cells stably transfected with human cytochrome P4501A1 (CYP1A1) and a single copy of either NAT2*4 (rapid acetylator) or NAT2*5B (slow acetylator) alleles were used to test the effect of CYP1A1 and NAT2 polymorphism on PhIP genotoxicity. Cells transfected with NAT2*4 had significantly higher levels of N-hydroxy-PhIP O-acetyltransferase (p = 0.0150) activity than cells transfected with NAT2*5B. Following PhIP treatment, CHO cell lines transfected with CYP1A1, CYP1A1/NAT2*4 and CYP1A1/NAT2*5B each showed concentration-dependent cytotoxicity and hypoxanthine phosphoribosyl transferase (hprt) mutagenesis not observed in untransfected CHO cells. dG-C8-PhIP was the primary DNA adduct formed and levels were dose dependent in transfected CHO cells in the order: CYP1A1 < CYP1A1 and NAT2*5B < CYP1A1 and NAT2*4, although levels did not differ significantly (p > 0.05) following one-way analysis of variance. These results strongly support activation of PhIP by CYP1A1 with little effect of human NAT2 genetic polymorphism on mutagenesis and DNA damage.

Assessing the effect of increasing injection activity for myocardial perfusion imaging in overweight patients.

In our previous publication, we proposed to increase the injection activity for overweight patients. We have now implemented this for our patients, i.e. increasing the activity for patients above 99 kg. In the present study, we audited whether this increased activity for overweight patients improved the myocardial counts effectively and also whether it improved the image quality for these patients. 125 consecutive normal myocardial perfusion studies were included into the study. The total left ventricular myocardial count was calculated, as was the total left ventricular myocardial volume using the Cedar Sinai QPS program. The myocardial count per millilitre of the myocardium (c ml(-1)) was correlated with patient weight using regression analysis. There was no significant difference (p = 0.120) among the mean myocardial counts for patients over 99 kg (n = 40, 1548 c ml(-1)) compared with patients in the 70-79 kg range (n = 26, 1746 c ml(-1)). This indicates that the previously proposed algorithm for adjusting injection activity maintains the count density in the myocardium and should be used for all patients over 99 kg. There was, however, a significant steady decrease with increased weight in the myocardial counts for patients under 100 kg (p<0.001), a range in which injection activity was not adjusted for weight. To correct for this, we now propose that the injection activity should be adjusted for all patients over 80 kg, using the previously proposed algorithm.

Use of Resistant Cultivars and Reduced Fungicide Programs to Manage Peanut Diseases in Irrigated and Nonirrigated Fields.

Field experiments were conducted in 2004 and 2005 to evaluate the response of several peanut cultivars to standard and reduced-input fungicide programs under production systems which differed in the duration of crop rotation, disease history within a field, or in the presence or absence of irrigation. Effects on early leaf spot (caused by Cercospora arachidicola), late leaf spot (caused by Cercosporidium personatum), and southern stem rot (caused by Sclerotium rolfsii), pod yields, and economic returns were assessed. Standard fungicide programs were similar for both sets of experiments and included applications of pyraclostrobin, tebuconazole, azoxystrobin, or chlorothalonil. Reduced-fungicide programs, comprising combinations of the aforementioned fungicides, resulted in two and four applications for the cultivar and irrigation experiment, respectively. Two additional programs (a seven-spray chlorothalonil and a nontreated control) were included in the cultivar experiment. Fungicide programs provided adequate levels of leaf spot suppression, and stem rot incidence was similar among fungicide programs within the two management systems. In the cultivar experiment, returns were significantly lower for the reduced program compared with the full program and seven-spray chlorothalonil program; however, they were significantly higher than the nontreated control. Significant differences in leaf spot, stem rot, and yield were observed among cultivars in both experiments. Overall, leaf spot intensity was lowest for the cvs. Georgia-03L and Georgia-01R and greatest for Georgia Green and Georgia-02C. Georgia-03L, Georgia-02C, and AP-3 consistently had lower incidence of stem rot than the other cultivars. Pod yields for all cultivars were equivalent to or greater than Georgia Green in both experiments; however, the performance of reduced-fungicide programs was inconsistent.

Integrated Disease Management of Leaf Spot and Spotted Wilt of Peanut.

Field experiments were carried out to evaluate the effects of integrated management of early leaf spot, caused by Cercospora arachidicola, and spotted wilt, caused by Tomato spotted wilt virus (TSWV), on peanut (Arachis hypogaea) using host resistance, two tillage systems, and varying fungicide programs. Effects on pod yield and economic return were assessed. Genotypes C-11-2-39 and Tifrunner demonstrated the best field resistance to TSWV, whereas cvs. DP-1 and GA-01R and line C-28-305 were among the genotypes with the best leaf spot resistance. Epidemics of both diseases were comparable or suppressed in strip-tilled plots compared with conventionally tilled plots. Leaf spot intensity decreased with increased fungicide applications, but to a lesser degree with use of resistance and strip tillage. Yields and net returns were similar between tillage treatments in 2002 and lower in strip tillage in 2003. Genotypes with the greatest yields and returns were C-11-2-39, C-99R, and GA-01R. Returns were comparable among the four-, five-, and seven-spray programs in both years, despite differences in yield. The standard production system, Georgia Green in conventional tillage with seven sprays, resulted in lower returns than half the integrated systems tested in 2002, but had comparable or higher returns than nearly all systems in 2003. When significant, yields and returns were correlated with spotted wilt intensity to a greater degree than leaf spot intensity.

Adaptive Real-Time Closed-Loop Temperature Control for Ultrasound Hyperthermia Using Magnetic Resonance Thermometry.

Previous researchers have successfully demonstrated the application of temperature feedback control for thermal treatment of disease using MR thermometry. Using the temperature-dependent proton resonance frequency (PRF) shift, ultrasound heating for hyperthermia to a target organ (such as the prostate) can be tightly controlled. However, using fixed gain controllers, the response of the target to ultrasound heating varies with type, size, location, shape, stage of growth, and proximity to other vulnerable organs. To adjust for clinical variables, feedback self-tuning regulator (STR) and model reference adaptive control (MRAC) methods have been designed and implemented using real-time, online MR thermometry by adjusting the output power to an ultrasound array to quickly reach the hyperthermia target temperatures. The use of fast adaptive controllers in this application is advantageous because adaptive controllers do not require a priori knowledge of the initial tissue properties and blood perfusion and can quickly reach the steady-state target temperature in the presence of dynamic tissue properties (e.g., thermal conductivity, blood perfusion). This research was conducted to rapidly achieve and manage therapeutic temperatures from an ultrasound array using novel MRI-guided adaptive closed-loop controllers both in ex vivo and in vivo experiments. The ex vivo phantom experiments with bovine muscle (n = 5) show that within 6 ± 0.2 minutes, the tissue temperature increased by 8 ± 1.37°C. Using rabbits' (n = 5) thigh muscle, the in vivo experiments demonstrated the target temperature reached 44.5°C ± 1.2°C in 8.0 ± 0.5 minutes. The preliminary in vivo experiment with canine prostate hyperthermia achieved 43 ± 2°C in 6.5 ± 0.5 minutes. These results demonstrate that the adaptive controllers with MR thermometry are able to effectively track the target temperature with dynamic tissue properties.

Two-dimensional ultrasound phased array design for tissue ablation for treatment of benign prostatic hyperplasia.

This paper describes the design, construction and evaluation of a two-dimensional ultrasound phased array to be used in the treatment of benign prostatic hyperplasia. With two-dimensional phased arrays, the focal point position can be controlled by changing the electrical power and phase to the individual elements for focusing and electronically steering in a three-dimensional volume. The array was designed with a steering angle of +/-14 degrees in both transverse and longitudinal directions. A piezoelectric ceramic (PZT-8) was used as the material of the transducer, since it can handle the high power needed for tissue ablation and a matching layer was used for maximum acoustic power transmission to tissue. Analysis of the transducer ceramic and cable impedance has been designed for high power transfer with minimal capacitance and diameter. For this initial prototype, the final construction used magnet compatible housing and cabling for future application in a clinical magnetic resonance imaging system for temperature mapping of the focused ultrasound. To verify the capability of the transducer for focusing and steering, exposimetry was performed and the results correlated well with the calculated field. Ex vivo experiments were performed and indicated the capability of the transducer to ablate tissue using short sonications. For sonications with exposure time of 10, 15 and 20 s, the lesion size was roughly 1.8, 3.0 and 4.3 mm in diameter, respectively, which indicates the feasibility of this device.

Thermal effects of focused ultrasound energy on bone tissue.

The effects of focused ultrasound (US) at therapeutic acoustic power levels were studied in vivo on the bone-muscle interface in rabbit thighs. The purpose of this study was to provide direction in establishing safety guidelines for treating tissue masses using focused US on or near bone. A positioning device was used to manipulate a focused US transducer (1.5 MHz) in a magnetic resonance imaging (MRI) scanner. This system was used to sonicate the femurs of 10 rabbits at acoustic power levels of 26, 39, 52 and 65 W for 10 s. The rabbits were euthanized either 4 h or 28 days after the sonications and the bone samples were harvested for histology examinations. In the femurs studied, acoustic power levels from 39 to 65 W resulted in soft tissue damage characterized grossly by coagulated tissue and bone damage depicted by yellow discoloration. Histologic examination of lesions from sonications from 39 to 65 W demonstrated that osteocyte damage and necrosis, characterized by pyknotic cells and empty lacunae, occurred within the ablation area extending through the bone. The follow-up MR images demonstrated an increase in the amount of damage in the femurs at 28 days posttreatment in comparison to images taken immediately after treatment. Focused US directed at the femur caused immediate significant thermal damage to bone in the form of osteocyte necrosis extending through the (approximately) 1 cm bone in this study. The results suggest that, when focused US energy is directed at or near bone-muscle interfaces, precautions should be taken to avoid thermal damage to the bone that can compromise its strength for extended periods.

Control system for an MRI compatible intracavitary ultrasound array for thermal treatment of prostate disease.

A 16-channel ultrasound intracavitary array is currently being used in a clinical setting for localized hyperthermia treatment of prostate tumours. Currently, the individual power to each array element is adjusted based on the clinician's judgement of the temperature measured at the locations of invasive thermocouple probes. MRI-derived temperature measurements may be useful for a feedback control system that non-invasively regulates the temperature distribution by adjusting the power to the elements of the array. MRI has been shown to provide accurate, high resolution, non-invasive thermometry. A proportional-plus-integral, single-input, single-output controller was designed to evaluate the feasibility of MRI-derived temperature feedback with this applicator. Input parameters for the controller were determined by modelling the tissue response to the heating from the array. Ex vivo and in vivo experiments evaluated the ability of the MRI-based temperature feedback control system to achieve and maintain a target temperature for a sustained period similar to that of a clinical hyperthermia treatment. With the controller set to a reference temperature of 43 degrees C and a rise time of 6 min, the temperatures within the ex vivo tissue (n = 6) were 43.1 +/- 0.3 degrees C after reaching the reference temperature and had a rise time of 9.5 +/- 0.3 min. In vivo results using rabbit thigh muscle (n = 7) showed that the steady state temperatures were within +/- 1 degree C of their target temperatures. These results demonstrated the feasibility of a temperature feedback for controlling the heating from an intracavitary transrectal array based on temperature information from MR images.

Metabolism of DHEA by cytochromes P450 in rat and human liver microsomal fractions.

Administration of dehydroepiandrosterone (DHEA) to rodents produces many unique biological responses, some of which may be due to metabolism of DHEA to more biologically active products. In the current study, DHEA metabolism was studied using human and rat liver microsomal fractions. In both species, DHEA was extensively metabolized to multiple products; formation of these products was potently inhibited in both species by miconazole, demonstrating a principal role for cytochrome P450. In the rat, use of P450 form-selective inhibitors suggested the participation of P4501A and 3A forms in DHEA metabolism. Human liver samples displayed interindividual differences in that one of five subjects metabolized DHEA to a much greater extent than the others. This difference correlated with the level of P4503A activity present in the human liver samples. For one subject, troleandomycin inhibited hepatic microsomal metabolism of DHEA by 78%, compared to 81% inhibition by miconazole, suggesting the importance of P4503A in these reactions. Form-selective inhibitors of P4502D6 and P4502E1 had a modest inhibitory effect, suggesting that these forms may also contribute to metabolism of DHEA in humans. Metabolites identified by LC-MS in both species included 16alpha-hydroxy-DHEA, 7alpha-hydroxy-DHEA, and 7-oxo-DHEA. While 16alpha-hydroxy-DHEA appeared to be the major metabolite produced in rat, the major metabolite produced in humans was a mono-hydroxylated DHEA species, whose position of hydroxylation is unknown.

Docosahexaenoic acid reverses cyclosporin A-induced changes in membrane structure and function.

The use of a fish oil vehicle for cyclosporin A (CsA) can decrease the toxic effects of CsA but the mechanism is unclear. Here we examine the mechanism by which docosahexaenoic acid (DHA), a fish oil-derived polyunsaturated fatty acid, can alter the toxic effects of CsA on mouse organ function, endothelial macromolecular permeability, and membrane bilayer function. Mice given CsA and fish oil showed increased liver toxicity, kidney toxicity, incorporation of DHA, and evidence of oxidized fatty acids compared to control animals. We hypothesized that the toxic effects of CsA were primarily a result of membrane perturbation, which could be decreased if DHA were not oxidized. The presence of CsA (10 mol%) alone increased dipalmitoylphosphatidylcholine membrane permeability by seven fold over control (no CsA, no DHA). However, if non-oxidized DHA (15 mol%) and CsA were added to the membrane, the permeability returned to control levels. Interestingly, if the DHA was oxidized, the antagonistic effect of DHA on CsA was completely lost. While CsA alone increased endothelial permeability to albumin, the combination of non-oxidized DHA and CsA had no effect on endothelial macromolecular permeability. However the combination of oxidized DHA and CsA was no different than the effects of CsA only. CsA increased the fluorescence anisotropy of DPH in the liquid crystalline state of DPPC, while DHA decreased fluorescence anisotropy. However the combination of CsA and DHA was no different than DHA alone. We conclude that non-oxidized DHA can reverse the membrane perturbing effects of CsA, and the increases in endothelial macromolecular permeability, which may explain how fish oil is capable of decreasing the toxicity of CsA.

Estimation of ascitic fluid volume using 99Tcm labelled macroaggregated albumin.

We have assessed the usefulness of a radionuclide dilution method for estimation of ascitic fluid volume. 99Tc(m) macroaggregated albumin (10 MBq) was injected into the peritoneal fluid. Multiple samples were taken using a trocath peritoneal dialysis catheter over a 4-h period. Blood samples were taken at the same time and a 4-h urine collection was made during the study. At 4 h a controlled drainage of ascitic fluid, followed by suction drainage, was used and a total drained volume measured. For comparison, peritoneal volumes were measured from the radioactivity of peritoneal fluid activity samples using dilution techniques. The estimated peritoneal fluid volume using the radionuclide method was consistently higher than the drained volume. This was attributed to either a lack of uniform distribution of the activity in the peritoneal cavity by 4 h or early breakdown and absorption of activity from the peritoneal cavity. In two patients it was not possible to measure a volume due to poor distribution of the radionuclide in the peritoneal fluid. We found that in our group of patients the radionuclide dilution is of little value in estimating the peritoneal fluid volume.

In vivo demonstration of noninvasive thermal surgery of the liver and kidney using an ultrasonic phased array.

A 256-element, continuous-wave ultrasonic phased array has been used to thermally coagulate deep-seated liver and kidney tissue. The array elements were formed on a 1-3 piezocomposite bowl with a 10-cm radius of curvature and 12-cm diameter. The 0.65 x 0.65 cm2 projection elements were driven at 1.1 MHz by a custom-built amplifier system. A series of in vivo porcine experiments demonstrated the ability to coagulate liver and kidney tissue using the large-scale phased array. The temperature response of the treatment was guided and monitored using magnetic resonance (MR) images. Focal lesion volumes greater than 0.5 cm3 in kidney and 2 cm3 in liver were formed from a single 20-s sonication.

Transrectal ultrasound applicator for prostate heating monitored using MRI thermometry.

PURPOSE: For potential localized hyperthermia treatment of tumors within the prostate, an ultrasound applicator consisting entirely of nonmagnetic materials for use with magnetic resonance imaging (MRI) has been developed and tested on muscle tissue ex vivo and in vivo. METHODS AND MATERIALS: A partial-cylindrical intracavitary transducer consisting of 16 elements in a 4 x 4 pattern was constructed. It produced a radially propagating acoustic pressure field. Each element of this array (1.5 x 0.75 cm), operating at 1.5 MHz, could be separately powered to produce a desired energy deposition pattern within a target volume. Spatial and temporal temperature elevations were determined using the temperature-dependent proton resonant frequency (PRF) shift and phase subtraction of MR images acquired during ultrasonic heating. Four rabbits were exposed to the ultrasound to raise the local tissue temperature to 45 degrees C for 25 minutes. Six experiments compared thermocouple temperature results to PRF shift temperature results. RESULTS: The tests showed that the multi-element ultrasound applicator was MRI-compatible and allowed imaging during sonication. The induced temperature distribution could be controlled by monitoring the RF power to each transducer element. Therapeutic temperature elevations were easily achieved in vivo at power levels that were about 16% of the maximum system power. From the six thermocouple experiments, comparison between the thermocouple temperature and the PRF temperature yielded an average error of 0.34+/-0.36 degrees C. CONCLUSIONS: The MRI-compatible intracavitary applicator and driving system was able to control the ultrasound field and temperature pattern in vivo. MRI thermometry using the PRF shift can provide adequate temperature accuracy and stability for controlling the temperature distribution.